//
Alexion Access Foundation is a private corporation based in NEW HAVEN, CT. The foundation received its IRS ruling in 2008. The principal officer is % John Markow Esq. It holds total assets of $1. Annual income is reported at $144.8M. PROVIDES CERTAIN ALEXION PRODUCTS AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD PRESCRIBED PRODUCTS. According to available records, Alexion Access Foundation has made 5 grants totaling $121.1M, with a median grant of $27.9M. Individual grants have ranged from $3.9M to $42.4M, with an average award of $24.2M. The foundation has supported 5 unique organizations. Grant recipients are concentrated in Connecticut. Contributions to this foundation are tax-deductible.
PROVIDES CERTAIN ALEXION PRODUCTS AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD PRESCRIBED PRODUCTS.
Expenses: $121.1M
PROVIDES CERTAIN ALEXION PRODUCTS AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD PRESCRIBED PRODUCTS. Based on available records, the foundation has funded 5 grants. Its grantmaking reaches organizations primarily in CT.
Alexion Access Foundation has distributed a total of $121.1M across 5 grants. The median grant size is $27.9M, with an average of $24.2M. Individual grants have ranged from $3.9M to $42.4M.
ELIGIBLE PARTICIPANTS IN THE ALEXION ACCESS FOUNDATION PROGRAM ARE GENERALLY REQUIRED TO MEET, AMONG OTHER THINGS, MEDICAL, INSURANCE AND FINANCIAL CRITERIA TO BE ELIGIBLE FOR SUPPORT.
Alexion Access Foundation is headquartered in NEW HAVEN, CT.
| Name | Title | Compensation | Benefits | Total |
|---|---|---|---|---|
| Eric Rogers | PRESIDENT/DIRECTOR | $0 | $0 | $0 |
| Tamar Thompson | DIRECTOR | $0 | $0 | $0 |
| Isabel Firmino | DIRECTOR | $0 | $0 | $0 |
Total Giving
$110.3M
Total Assets
$101K
Fair Market Value
$101K
Net Worth
$101K
Grants Paid
$110.2M
Contributions
$110.2M
Net Investment Income
$0
Distribution Amount
$0
Total Grants
5
Total Giving
$121.1M
Average Grant
$24.2M
Median Grant
$27.9M
Unique Recipients
5
Most Common Grant
$3.9M
| Recipient | Location | Amount | Year |
|---|---|---|---|
| Vials Of Strensiq Were DistributedPROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PRODUCT | New Haven, CT | $42.4M | 2022 |
| Vials Of Soliris Were Distributed TPROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PRODUCT | New Haven, CT | $42.2M | 2022 |
| Vials Of Ultomiris Were DistributedPROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PRODUCT | New Haven, CT | $27.9M | 2022 |
| Vials Of Koselugo Were DistributedPROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PRODUCT | New Haven, CT | $4.8M | 2022 |
| Vials Of Kanuma Were Distributed ToPROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PRODUCT |
| New Haven, CT |
| $3.9M |
| 2022 |
© 2026 Granted AI